More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
NextGov/FCW’s Meet the Chiefs: Chief Artificial Intelligence
Our experts will meet with federal leaders on practical AI adoption for government to create systems built to last beyond pilots.
Centers for Medicare and Medicaid Industry Forum 2026
As CMS systems modernize, Abt meets mission with proven methods.
2026 Coalition for Common Sense in Government Procurement Winter Training Conference
Our experts look forward to exploring how we will use evidence, analytics, and disciplined implementation to improve program outcomes.
2026 Ohio Deflection Association Summit
Join Dr. Allison Dymnicki to explore data-driven deflection: What’s working, what’s next?